Veracyte, Inc.
Status: Publicly traded
Direct answer
Veracyte, Inc. is publicly traded on NASDAQ under the ticker VCYT.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer...
Can you invest in Veracyte, Inc.?
Yes. Veracyte, Inc. is publicly traded on NASDAQ under the ticker VCYT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Veracyte, Inc.
Detailed equity research is provided by MarketSnap.